Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Latest From Abbott

Generics And Biosimilars Industry Reshaped By Transformations

The latest Generics Bulletin Top 50 ranking of global generics and biosimilars companies sees a new name in the top five amid transformations for some of the leading off-patent players. Meanwhile, a number of mid-level firms shift position and newcomers climb into the bottom of the table.

Outlook 2023 Generic Drugs

Perrigo Supports Hypoallergenic Infant Formula Savings Claims, Not Equivalence To Enfamil Brand

Perrigo can continue claiming its store brand hypoallergenic infant formula saves customers more than 20% compared to leading name brands while providing similar nutrition to leading brands. But meeting AAP standard doesn’t measure up as equivalent to brands, industry self-regulation group says.

Enforcement Advertising, Marketing & Sales

Keeping Track: Rebyota, Rezlidhia Rev Up US FDA Approvals; New Sponsors Sought For Poziotinib, Brexafemme

The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.

US FDA Performance Tracker Approvals

Medtech Challenged To Build On 2021 Amid Threats Of Recession: Views From Industry Leaders

Strong headwinds beset the medtech industry as 2022 draws to a close, including supply chain, fundraising and labor shortages. However, optimism prevailed among medtech industry leaders discussing EY’s annual Pulse of the Industry medical technology report and related topics at AdvaMed’s 2022 MedTech Conference.

Financing Business Strategies
See All

Company Information

  • Industry
  • Medical Devices
  • Pharmaceuticals
  • Pharmaceuticals
    • Generic Drugs
    • Nutraceuticals
  • Medical Devices
    • Diagnostic Equipment & Supplies
    • Implantable Devices
    • Monitoring Equipment & Devices
    • Surgical Equipment & Devices
  • Other Names / Subsidiaries
    • Abbott Diabetes Care, Inc.
    • Abbott Laboratories
    • Abbott Medical Optics
    • Advanced Medical Optics, Inc.
    • AMO Manufacturing USA, LLC
    • Advanced Neuromodulation Systems
    • AGA Medical Corporation
    • Alere, Inc.
    • Axis-Shield plc
    • Binax, Inc.
    • Biosite, Inc.
    • CardioMEMS
    • Cephea Valve Technologies
    • CFR Pharmaceuticals S.A.
    • Cholestech Corporation
    • Domestic Formulations
    • Endocardial Solutions, Inc.
    • Endosense SA
    • EP Medsystems
    • Epicor Medical, Inc.
    • Evalve Inc.
    • Facet Biotech Corporation
    • Fournier Pharma
    • Free & Clear, Inc.
    • Garden Hills
    • Guidant Corporation Vascular Device Division
    • Ibis Biosciences
    • IDEV Technologies
    • Innogenetics nv
    • Inverness Medical Innovations Inc.
    • Irvine Biomedical
    • Kos Pharmaceuticals, Inc.
    • MediGuide Inc.
    • MediSense
    • Nanostim
    • Inc.
    • Neuromed Inc.
    • NeuroTherm Inc
    • Northstar Neuroscience, Inc.
    • OptiMedica Corporation
    • Ostex International Inc.
    • Pacesetter
    • Piramal Healthcare Solutions
    • Quest Medical, Inc.
    • Radi Medical Systems AB
    • Spinal Modulation, Inc.
    • Solvay Pharmaceuticals, Inc. (Unimed Pharmaceuticals, Inc.)
    • Spinal Concepts
    • St. Jude Medical, Inc.
    • Tendyne Holdings, Inc.
    • TheraSense, Inc.
    • Thoratec Corporation
    • Topera, Inc.
    • US Diagnostics (USD)
    • Velocimed, Inc.
    • Ventritex
    • Veropharm
    • Walk Vascular, LLC
UsernamePublicRestriction

Register